|1.||Wan, Mei: 2 articles (07/2009 - 08/2007)|
|2.||Zheng, Jun-Nian: 1 article (08/2015)|
|3.||Pei, Dong-Sheng: 1 article (08/2015)|
|4.||Du, Wen-Qi: 1 article (08/2015)|
|5.||Zhang, Rui-Yan: 1 article (08/2015)|
|6.||Sang, Miao-Miao: 1 article (08/2015)|
|7.||Schütz, Anke K: 1 article (06/2012)|
|8.||Jumpertz, Sandra: 1 article (06/2012)|
|9.||Bernhagen, Jürgen: 1 article (06/2012)|
|10.||Fuchs, Simone: 1 article (06/2012)|
08/01/2015 - "As one of the COP9 signalosome complex, CSN5 (also known as Jab1) has been confirmed overexpression in many human cancers and affected multiple pathways associating with cell proliferation and apoptosis. "
12/01/2005 - "In the last several years, multiple lines of evidence have suggested that the COP9 signalosome (CSN) plays a significant role in the regulation of multiple cancers and could be an attractive target for therapeutic intervention. "
06/04/2012 - "CSN5/JAB1 is a critical subunit of the COP9 signalosome (CSN) and is overexpressed in many human cancers, but little is known about the role of CSN5 in colorectal cancer (CRC). "
07/01/2009 - "Jab1 (Jun activation domain binding protein 1), integrated into COP9 signalosome complex (CSN), induces protein instability of many tumor suppressors and cell cycle regulators and is therefore a novel target in cancer therapy. "
08/10/2007 - "Jab1, the fifth component of the COP9 signalosome complex, has a central role in the degradation of multiple proteins and is emerging as an important regulator in cancer development. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
|1.||Carrier Proteins (Binding Protein)
|2.||Proteins (Proteins, Gene)